-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only to read and refer to Alzheimer's disease is mostly preventable and controllable, and grasping these controllable risk factors is key
"Do you know what Alzheimer's disease (AD)?"
After a moment of silence.
Controlling controllable risk factors is the key to Professor Cui Mei, because AD lacks effective treatment methods and the disease development is irreversible, so early prevention is particularly important
.
Focus on these 6 aspects mentioned above, AD risk factors are divided into non-intervenable risk factors and interoperable risk factors, then, interoperable risk factors are our focus, in this regard, Professor Cui Mei briefly introduced 6 aspects: 1.Prevention of AD
From adolescence in the eyes of most people, AD is a disease that occurs in human old age and is closely related to aging, but Professor Cui Mei introduced to us: "At present, the academic community believes that AD prevention can be as early as adolescence
.
The focus is on the multiple prevention strategies for controllable risk factors described above in high-risk populations, all based on clinical recommendations
from evidence-based medicine.
Finally, we asked Professor Cui Mei for advice on the value of AD prevention for individuals, families and society, Professor Cui Mei said that once a person suffers from AD, symptoms such as memory decline and life ability decline will gradually worsen, and progress to the later stage of lack of self-awareness, inability to independently carry out normal life activities, and need personal care
from caregivers.Cui Mei
Where to look for more clinical knowledge of neurology?
- Deputy Chief Physician, Associate Researcher, Master Supervisor, and Doctor of Medicine, Department of Neurology, Huashan Hospital Affiliated to Fudan University
- Shanghai Youth Science and Technology Star
- Young member of the cerebrovascular disease group of the Neurology Branch of the Chinese Medical Association
- He is a member of the Youth Council of the Chinese Stroke Society
- He is a member of the Stroke Genetics Branch of the Chinese Stroke Society
- He is a member of the Cerebral Small Blood Vessel Branch of the Chinese Stroke Society
- He has long been engaged in clinical and basic research on cerebral small vascular disease and vascular related neurodegenerative diseases
- He undertook 1 sub-project of the 2030 "Brain Science and Brain-like Research" major project of the Ministry of Science and Technology, 3 National Natural Science Foundation of China, 1 Fund of the Ministry of Education and 3 projects of Shanghai Municipal Science and Technology Commission
- He has published more than 60 SCI articles as the first author or corresponding author, including Alzheimers Dement, Brain, PNAS, Nat Commun and other internationally renowned journals
Come to the "Doctor's Station" and take a look 👇Source of this articleMedical Neurology ChannelHope this article is reviewCui Mei Responsible Editor of Huashan Hospital
Affiliated to Fudan UniversityMr.
Lu Li Xiang Yu
Copyright noticeThis
article is original, reproduced please contact the authorization-End-submitted/reprinted/business cooperation, please contact: yxjsjbx@yxj.
org.
cn*The medical community strives to be accurate and reliable when the published content is approved, but does not make any commitment and guarantee for the timeliness of the published content, as well as the accuracy and completeness of the cited information (if any), etc.
, and does not assume that the content is outdated, Any liability arising from the possible inaccuracy or incompleteness of the referenced materials
.
Relevant parties are invited to verify separately when adopting or using this as a basis for decision-making
.